Zobrazeno 1 - 1
of 1
pro vyhledávání: '"bcd-057"'
Autor:
Т. V. Korotaeva, A. V. Samtsov, A. L. Bakulev, M. M. Kokhan, I. K. Minullin, O. A. Vylegzhanina, V. V. Dubensky, B. V. Khalilov, A. A. Khotko, O. S. Zykova, I. V. Chumachenko, A. M. Lukyanov, A. V. Artemyeva, S. I. Derbin, E. Yu. Stukalina, E. V. Chernyaeva, R. A. Ivanov
Publikováno v:
Современная ревматология, Vol 12, Iss 4, Pp 71-84 (2018)
The paper gives the results of the phase III clinical trial of adalimumab (ADA) biosimilar, (BCD-057) (BIOCAD, Russia), which demonstrate the clinical equivalence of the biosimilar to the ADA innovator Humira® in patients with moderate and severe ps
Externí odkaz:
https://doaj.org/article/dcfec1eedb564d51b6a28f18e8c990d5
